Proteins expressed by
View Patent ↗The invention provides polypeptides encoded by open reading frames present in the genome of Mycobacterium tuberculosis but absent from the genome of BCG and diagnostic and prophylactic methodologies using these polypeptides.
1. A method of in vitro diagnosis which discriminates between exposure of a subject to Mycobacterium tuberculosis and vaccination with the Bacille Calmette Guerin strain of Mycobacterium bovis , the method comprising testing for the presence of CD4 T lymphocytes that respond to MTBN4, wherein the presence of the CD4 T lymphocytes that respond to MTBN4 indicates that the subject has been exposed to Mycobacterium tuberculosis , and wherein CD4 T lymphocytes from a subject vaccinated with the Bacille Calmette Guerin strain of Mycobacterium bovis but not exposed to Mycobacterium tuberculosis do not respond.
2. The method of claim 1 , wherein the testing for the presence of CD4 T lymphocytes that respond to MTBN4 comprises contacting CD4 T lymphocytes from the subject with antigen presenting cells (APC) from the subject and MTBN4.
3. The method of claim 1 , wherein the testing for the presence of CD4 T lymphocytes that respond to MTBN4 comprises testing for cytokine production.
4. The method of claim 3 , wherein the cytokine measured is IFNγ.
5. The method of claim 1 , further comprising testing for the presence of CD4 T lymphocytes that respond to MTBN8.
6. A method of in vitro diagnosis which discriminates between exposure of a subject to Mycobacterium tuberculosis and vaccination with the Bacille Calmette Guerin strain of Mycobacterium bovis , the method comprising testing for the presence of B lymphocytes which produce an antibody that binds to MTBN4, wherein the presence of the B lymphocytes that produce an antibody that binds to MTBN4; indicates that the subject has been exposed to Mycobacterium tuberculosis , and wherein B lymphocytes from a subject vaccinated with the Bacille Calmette Guerin strain of Mycobacterium bovis but not exposed to Mycobacterium tuberculosis do not produce said antibody.
7. The method of claim 6 , wherein the testing for the presence of B lymphocytes that produce an antibody that binds to MTBN4 comprises:
(a) contacting a bodily fluid from the subject with a composition comprising MTBN4; and
(b) testing for binding of the antibody in the bodily fluid to MTBN4.
8. The method of claim 7 , wherein the bodily fluid is blood.
9. The method of claim 7 , wherein the bodily fluid is plasma or serum.
10. The method of claim 6 , further comprising testing for the presence of B lymphocytes which produce an antibody that binds to MTBN8.
11. A method of in vitro diagnosis which discriminates between exposure of a subject to Mycobacterium tuberculosis and vaccination with the Bacille Calmette Guerin strain of Mycobacterium bovis , the method comprising testing for the presence of lymphocytes that respond to MTBN4, wherein the presence of the lymphocytes that respond to MTBN4 indicates that the subject has been exposed to Mycobacterium tuberculosis , and wherein lymphocytes from a subject vaccinated with the Bacille Calmette Guerin strain of Mycobacterium bovis but not exposed to Mycobacterium tuberculosis do not respond.
12. The method of claim 11 , further comprising testing for the presence of lymphocytes that respond to MTBN8.
13. A method of in vitro diagnosis which discriminates between exposure of a subject to Mycobacterium tuberculosis and vaccination with the Bacille Calmette Guerin strain of Mycobacterium bovis , the method comprising testing for the presence of a cytokine produced by CD4 T lymphocytes that respond to MTBN4, wherein the presence of the cytokines produced by CD4 T lymphocytes that respond to MTBN4 indicates that the subject has been exposed to Mycobacterium tuberculosis , and wherein CD4 T lymphocytes from a subject vaccinated with the Bacille Calmette Guerin strain of Mycobacterium bovis but not exposed to Mycobacterium tuberculosis do not respond.